Literature DB >> 3117606

Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.

S Lightman1, E Rechthand, H Terubayashi, A Palestine, S Rapoport, P Kador.   

Abstract

Permeability-surface-area products (PA) for sucrose at the blood-retinal barrier (BRB) were determined with quantitative in vivo techniques and compared in control rats, rats fed a 50% galactosemic diet, and rats fed a diet containing both galactose and the aldose reductase inhibitor sorbinil. The mean PA +/- SE for controls was 0.656 x 10(-5) +/- 0.13 ml.g-1.s-1 and increased by approximately 500% in galactose-fed animals to 3.13 x 10(-5) +/- 0.32 ml.g-1.s-1. Animals fed both galactose and sorbinil showed no significant difference from control animals (P greater than .05), with a PA of 0.91 x 10(-5) +/- 0.22 ml.g-1.s-1. No breach in the BRB to horseradish peroxidase was detected in any of the groups. These results demonstrate an increased permeability at the BRB to small molecules in galactosemic rats that is prevented by an aldose reductase inhibitor. This suggests that the retinal capillary basement membrane thickening seen in galactosemic rats is associated with an increased permeability of the BRB and that aldose reductase is implicated in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117606     DOI: 10.2337/diab.36.11.1271

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Immunohistochemical localization of blood-retinal barrier breakdown in human diabetics.

Authors:  S A Vinores; C Gadegbeku; P A Campochiaro; W R Green
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

2.  Experimental nonenzymatic glycosylation of vitreous collagens occurs by two pathways.

Authors:  J S Pulido
Journal:  Trans Am Ophthalmol Soc       Date:  1996

3.  Regulation of glucose transporter (GLUT 3) and aldose reductase mRNA inbovine retinal endothelial cells and retinal pericytes in high glucose and high galactose culture.

Authors:  R M Knott; M Robertson; J V Forrester
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

4.  Electron microscopic immunocytochemical demonstration of blood-retinal barrier breakdown in human diabetics and its association with aldose reductase in retinal vascular endothelium and retinal pigment epithelium.

Authors:  S A Vinores; E Van Niel; J L Swerdloff; P A Campochiaro
Journal:  Histochem J       Date:  1993-09

5.  The effects of an aldose reductase inhibitor on the progression of diabetic retinopathy.

Authors:  A Tromp; J M Hooymans; B C Barendsen; J J van Doormaal
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

6.  Plasma 1,5-anhydroglucitol in experimental galactosemia in the rat.

Authors:  E Pitkänen; O M Pitkänen
Journal:  Experientia       Date:  1990-01-15

Review 7.  The role of polyols in the pathophysiology of hypergalactosemia.

Authors:  G T Berry
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

Review 8.  Pathophysiology of diabetic retinopathy.

Authors:  Joanna M Tarr; Kirti Kaul; Mohit Chopra; Eva M Kohner; Rakesh Chibber
Journal:  ISRN Ophthalmol       Date:  2013-01-15

Review 9.  Extracellular vesicles: mediators and biomarkers of pathology along CNS barriers.

Authors:  Servio H Ramirez; Allison M Andrews; Debayon Paul; Joel S Pachter
Journal:  Fluids Barriers CNS       Date:  2018-07-01

Review 10.  Extracellular Vesicles as Signaling Mediators and Disease Biomarkers across Biological Barriers.

Authors:  Pasquale Simeone; Giuseppina Bologna; Paola Lanuti; Laura Pierdomenico; Maria Teresa Guagnano; Damiana Pieragostino; Piero Del Boccio; Daniele Vergara; Marco Marchisio; Sebastiano Miscia; Renato Mariani-Costantini
Journal:  Int J Mol Sci       Date:  2020-04-04       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.